Lonza to Expand Manufacturing Capacity at Swiss Site

By MarketWatch | Nov 12, 2024 at 01:45 AM EST

Lonza Group to expand manufacturing capacity in Switzerland to meet demand for cancer drugs like antibody-drug conjugates. The company plans to add two manufacturing suites and infrastructure, creating 200 new jobs by 2028. Contact Adria Calatayud at adria.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.